Pro-Inflammatory and Anti-Inflammatory Mesenchymal Stem Cells (printable) 

Tulane University is actively seeking commercial entities to further develop and commercialize a novel method of producing mesenchymal stem cells (MSCs) that can be stored and used to predictably enhance or inhibit inflammation.

 

Applications

• Localized anti-inflammatory therapy for the following diseases: arthritis, inflammatory bowel disease, Crohn's disease, acute lung injury, chronic pain and organ rejection
• Localized pro-inflammatory therapy to enhance the immune response for patients with cancer, pathogenic infections, and other immune diseases
• Treatment of acute or chronic conditions
   

Advantages

Development Status

This technology has been tested extensively by in vitro assays and in several mouse models with success. Laboratory work is ongoing for further data and to ensure scalability.